Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Benimetskaya

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 7, 2000
Cellular delivery of antisense oligonucleotidesI Lebedeva, L Benimetskaya, C A Stein, et al.
Nucleic Acids Research|July 1, 1997
Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotideL Benimetskaya, M Berton, A Kolbanovsky, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 11, 1999
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localizationM Berton, L Benimetskaya, E Allémann, et al.
Nature Biotechnology|January 14, 2000
Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequencesM Ma, L Benimetskaya, I Lebedeva, et al.
Biochemical Pharmacology|July 29, 1999
Omega-6 polyunsaturated fatty acid-stimulated cellular internalization of phosphorothioate oligodeoxynucleotides: evidence for protein kinase C-zeta dependencyZ Khaled, Y Y Ho, L Benimetskaya, et al.
Nucleic Acids Research|November 25, 1998
Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotidesL Benimetskaya, G B Takle, M Vilenchik, et al.
Cancer Gene Therapy|October 1, 2005
Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signatureE M Anderson, P Miller, D Ilsley, et al.
Nucleic Acids Research|February 15, 1996
Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotidesZ Khaled, L Benimetskaya, R Zeltser, et al.
Nucleic Acids Research|November 11, 1995
Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independentL Benimetskaya, J L Tonkinson, M Koziolkiewicz, et al.
Antisense & Nucleic Acid Drug Development|July 21, 1998
A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formationW Wang, H J Chen, J Sun, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 7, 2000
Cellular delivery of antisense oligonucleotidesI Lebedeva, L Benimetskaya, C A Stein, et al.
Nucleic Acids Research|July 1, 1997
Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotideL Benimetskaya, M Berton, A Kolbanovsky, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 11, 1999
Uptake of oligonucleotide-loaded nanoparticles in prostatic cancer cells and their intracellular localizationM Berton, L Benimetskaya, E Allémann, et al.
Nature Biotechnology|January 14, 2000
Intracellular mRNA cleavage induced through activation of RNase P by nuclease-resistant external guide sequencesM Ma, L Benimetskaya, I Lebedeva, et al.
Biochemical Pharmacology|July 29, 1999
Omega-6 polyunsaturated fatty acid-stimulated cellular internalization of phosphorothioate oligodeoxynucleotides: evidence for protein kinase C-zeta dependencyZ Khaled, Y Y Ho, L Benimetskaya, et al.
Nucleic Acids Research|November 25, 1998
Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotidesL Benimetskaya, G B Takle, M Vilenchik, et al.
Cancer Gene Therapy|October 1, 2005
Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signatureE M Anderson, P Miller, D Ilsley, et al.
Nucleic Acids Research|February 15, 1996
Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotidesZ Khaled, L Benimetskaya, R Zeltser, et al.
Nucleic Acids Research|November 11, 1995
Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independentL Benimetskaya, J L Tonkinson, M Koziolkiewicz, et al.
Antisense & Nucleic Acid Drug Development|July 21, 1998
A comparison of guanosine-quartet inhibitory effects versus cytidine homopolymer inhibitory effects on rat neointimal formationW Wang, H J Chen, J Sun, et al.
Pageof 2